StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) stock

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.34−0.08 (-5.63%)

Close on Nov 17, 2026Market cap $34.14MP/E –Yield –

BioRestorative Therapies operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

BioRestorative Therapies's operating cash flow for the twelve months ending Mar 31, 2026 was -$11.82M. For fiscal 2025 it was -$10.79M. The highest annual figure on record is -$729.22K in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.79M–
FY2024Dec 31, 2024-$8.23M–
FY2023Dec 31, 2023-$6.43M–
FY2022Dec 31, 2022-$5.91M–
FY2021Dec 31, 2021-$3.33M–
FY2020Dec 31, 2020-$1.96M–
FY2019Dec 31, 2019-$6.92M–
FY2018Dec 31, 2018-$5.10M–
FY2017Dec 31, 2017-$3.85M–
FY2016Dec 31, 2016-$5.00M–
FY2015Dec 31, 2015-$3.12M–
FY2014Dec 31, 2014-$3.23M–
FY2013Dec 31, 2013-$2.67M–
FY2012Dec 31, 2012-$3.18M–
FY2011Dec 31, 2011-$2.81M–
FY2010Dec 31, 2010-$729.22K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026-$3.81M–
Q4 FY2025Dec 31, 2025-$2.42M–
Q3 FY2025Sep 30, 2025-$2.90M–
Q2 FY2025Jun 30, 2025-$2.69M–
Q1 FY2025Mar 31, 2025-$2.78M–
Q4 FY2024Dec 31, 2024-$2.35M–
Q3 FY2024Sep 30, 2024-$1.70M–
Q2 FY2024Jun 30, 2024-$1.87M–
Q1 FY2024Mar 31, 2024-$2.32M–
Q4 FY2023Dec 31, 2023-$1.59M–
Q3 FY2023Sep 30, 2023-$1.18M–
Q2 FY2023Jun 30, 2023-$1.28M–
Q1 FY2023Mar 31, 2023-$2.38M–
Q4 FY2022Dec 31, 2022-$1.62M–
Q3 FY2022Sep 30, 2022-$1.45M–
Q2 FY2022Jun 30, 2022-$1.25M–
Q1 FY2022Mar 31, 2022-$1.59M–
Q4 FY2021Dec 31, 2021-$1.15M–
Q3 FY2021Sep 30, 2021-$629.36K–
Q2 FY2021Jun 30, 2021-$741.83K–
Q1 FY2021Mar 31, 2021-$813.70K–
Q4 FY2020Dec 31, 2020-$572.12K–
Q3 FY2020Sep 30, 2020-$523.06K–
Q2 FY2020Jun 30, 2020-$420.44K–
Q1 FY2020Mar 31, 2020-$448.65K–
Q4 FY2019Dec 31, 2019-$1.81M–
Q3 FY2019Sep 30, 2019-$1.71M–
Q2 FY2019Jun 30, 2019-$1.42M–
Q1 FY2019Mar 31, 2019-$1.98M–
Q4 FY2018Dec 31, 2018-$1.55M–
Q3 FY2018Sep 30, 2018-$1.35M–
Q2 FY2018Jun 30, 2018-$1.04M–
Q1 FY2018Mar 31, 2018-$1.16M–
Q4 FY2017Dec 31, 2017-$1.36M–
Q3 FY2017Sep 30, 2017-$509.16K–
Q2 FY2017Jun 30, 2017-$765.96K–
Q1 FY2017Mar 31, 2017-$1.22M–
Q4 FY2016Dec 31, 2016-$1.06M–
Q3 FY2016Sep 30, 2016-$1.21M–
Q2 FY2016Jun 30, 2016-$1.02M–

More BioRestorative Therapies figures

See a number that looks wrong?